Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without R...

por Kandula, Shravan, Switchenko, Jeffrey M., Harari, Saul, Fasola, Carolina, Mister, Donna, Yu, David S., Zelnak, Amelia B., Torres, Mylin A.
Publicado 2015

CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy

por Schlafstein, Ashley J., Withers, Allison E., Rudra, Soumon, Danelia, Diana, Switchenko, Jeffrey M., Mister, Donna, Harari, Saul, Zhang, Hui, Daddacha, Waaqo, Ehdaivand, Shahrzad, Li, Xiaoxian, Torres, Mylin A., Yu, David S.
Publicado 2018

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation

por Caliò, Anna, Eble, John N., Hes, Ondrej, Martignoni, Guido, Harari, Saul E., Williamson, Sean R., Brunelli, Matteo, Osunkoya, Adeboye O., Wang, Lisha, Comperat, Eva, Lopez-Beltran, Antonio, Wang, Mingsheng, Zhang, Shaobo, Curless, Kendra L., Post, Kristin M., Chang, Hsim-Yee, Luchini, Claudio, Baldrige, Lee Ann, MacLennan, Gregory T., Montironi, Rodolfo, Grignon, David J., Cheng, Liang
Publicado 2016